Visiting Scholars and Scientists

Renato Umeton

Visting Scientist

Biostatistics

renato_umeton@dfci.harvard.edu

Links

Overview

Affiliate, Dana-Farber Cancer Institute
Affiliate, Massachusetts Institute of Technology
Affiliate, Harvard T.H. Chan School of Public Health
Affiliate, Weill Cornell Medical

Bibliography

Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome.

Umeton R, Bellucci G, Bigi R, Romano S, Buscarinu MC, Reniè R, Rinaldi V, Pizzolato Umeton R, Morena E, Romano C, Mechelli R, Salvetti M, Ristori G.

Sci Rep. 2022 May 09. 12(1):7536. PMID: 35534508

Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.

Bychkovsky BL, Li T, Sotelo J, Tayob N, Mercado J, Gomy I, Chittenden A, Kane S, Stokes S, Hughes ME, Kim JS, Umeton R, Awad MM, Konstantinopoulos PA, Yurgelun MB, Wolpin BM, Taplin ME, Newmark RE, Johnson BE, Lindeman NI, MacConaill LE, Garber JE, Lin NU.

Clin Cancer Res. 2022 Apr 01. PMID: 35363308

Building Tools for Machine Learning and Artificial Intelligence in Cancer Research: Best Practices and a Case Study with the PathML Toolkit for Computational Pathology.

Rosenthal J, Carelli R, Omar M, Brundage D, Halbert E, Nyman J, Hari SN, Van Allen EM, Marchionni L, Umeton R, Loda M.

Mol Cancer Res. 2022 02. 20(2):202-206. PMID: 34880124

Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study.

Ferraldeschi M, Romano S, Giglio S, Romano C, Morena E, Mechelli R, Annibali V, Ubaldi M, Buscarinu MC, Umeton R, Sani G, Vecchione A, Salvetti M, Ristori G.

Front Neurol. 2021. 12:657973. PMID: 34025560

Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum.

Penney KL, Tyekucheva S, Rosenthal J, El Fandy H, Carelli R, Borgstein S, Zadra G, Fanelli GN, Stefanizzi L, Giunchi F, Pomerantz M, Peisch S, Coulson H, Lis R, Kibel AS, Fiorentino M, Umeton R, Loda M.

Mol Cancer Res. 2021 03. 19(3):475-484. PMID: 33168599

Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.

Albayrak A, Garrido-Castro AC, Giannakis M, Umeton R, Manam MD, Stover EH, Porter RL, Johnson BE, Liaw KL, Amonkar M, Church AJ, Janeway KA, Nowak JA, Sholl L, Lin NU, Johnson JM.

JCO Precis Oncol. 2020 Nov. 4:1084-1097. PMID: 35050773

Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer.

Lamberti G, Spurr LF, Li Y, Ricciuti B, Recondo G, Umeton R, Nishino M, Sholl LM, Meyerson ML, Cherniack AD, Awad MM.

Ann Oncol. 2020 06. 31(6):807-814. PMID: 32171752

Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer.

Ricciuti B, Recondo G, Spurr LF, Li YY, Lamberti G, Venkatraman D, Umeton R, Cherniack AD, Nishino M, Sholl LM, Shapiro GI, Awad MM, Cheng ML.

Clin Cancer Res. 2020 08 01. 26(15):4135-4142. PMID: 32332016

Automated machine learning: Review of the state-of-the-art and opportunities for healthcare.

Waring J, Lindvall C, Umeton R.

Artif Intell Med. 2020 04. 104:101822. PMID: 32499001

Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC.

Recondo G, Bahcall M, Spurr LF, Che J, Ricciuti B, Leonardi GC, Lo YC, Li YY, Lamberti G, Nguyen T, Milan MSD, Venkatraman D, Umeton R, Paweletz CP, Albayrak A, Cherniack AD, Price KS, Fairclough SR, Nishino M, Sholl LM, Oxnard GR, Jänne PA, Awad MM.

Clin Cancer Res. 2020 06 01. 26(11):2615-2625. PMID: 32034073

VIEW MORE PUBLICATIONS